Cogent Biosciences Inc (NASDAQ:COGT)
| 11.58 BATS BZX Real-Time Price As of 11:31am ET |  +0.11 / +0.96%Today’s Change | 3.79 Today|||52-Week Range 18.07 | +0.17% Year-to-Date |
Latest COGT News | Press Releases
No recent news for Cogent Biosciences Inc.
Today’s Trading
| Previous close | 11.47 |
| Today’s open | 11.41 |
| Day’s range | 11.25 - 11.60 |
| Volume | 1,262 |
| Average volume (3 months) | 729,631 |
| Market cap | $822.6M |
Data as of 11:31am ET, 03/20/2023
Growth & Valuation
| Earnings growth (last year) | -27.95% |
| Earnings growth (this year) | +6.93% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALLOAllogene Therapeutic... | -0.03 | -0.55% |
| ---- | ||
| RGNXRegenxbio Inc | +0.13 | +0.65% |
| IMGNImmunoGen Inc | -0.05 | -1.27% |
Data as of 11:36am ET, 03/20/2023
Financials
| Next reporting date | May 15, 2023 |
| EPS forecast (this quarter) | -$0.55 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$140.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
